Specificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model.

scientific article published on 2 October 2006

Specificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.TUBE.2006.06.002
P698PubMed publication ID17011827
P5875ResearchGate publication ID6782744

P50authorAlexander PichuginQ56424754
Alexander AptQ59668298
P2093author name stringElena Kondratieva
David McMurray
Svetlana Petrovskaya
Irina Baturina
Tatiana Kondratieva
Elvira Rubakova
Valentine Khlebnikov
P2860cites workRecombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal modelQ24675231
Dendritic cells and the control of immunityQ27860918
Immunology of tuberculosisQ29614370
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrowQ29615498
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factorQ29619247
The dendritic cell system and its role in immunogenicityQ29619870
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivoQ30080006
Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant miceQ33715964
An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosisQ33766722
Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysinQ33919973
Interaction of dendritic cells with mycobacteria: where the action startsQ34007420
Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosisQ34008163
Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.Q34119135
Variation in protection by BCG: implications of and for heterologous immunityQ34288541
Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysisQ34338450
Immunity to tuberculosisQ35698525
Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situQ36352646
Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivoQ36362128
A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in miceQ37623702
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosisQ38447962
Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivoQ40752701
Dendritic cells acquire antigens from live cells for cross-presentation to CTL.Q40822225
Immunological requirements for a subunit vaccine against tuberculosisQ40867776
Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in miceQ40894562
Origin, maturation and antigen presenting function of dendritic cells.Q40906220
Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis.Q41355790
Florid pulmonary inflammatory responses in mice vaccinated with Antigen-85 pulsed dendritic cells and challenged by aerosol with Mycobacterium tuberculosisQ44420174
Distinct H-2 complex control of mortality, and immune responses to tuberculosis infection in virgin and BCG-vaccinated miceQ44445984
Comparative analysis of mycobacterial infections in susceptible I/St and resistant A/Sn inbred mice.Q54044422
Comparative Analysis of Different Vaccine Constructs Expressing Defined Antigens fromMycobacterium tuberculosisQ57203132
Cytolytic T-cell responses to human dendritic cells and macrophages infected with Mycobacterium bovis BCG and recombinant BCG secreting listeriolysinQ57598880
Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literatureQ57752071
Bacille Calmette-Guérin adenitis 30 years after immunization in a patient with AIDSQ69753233
Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivoQ73100730
Potent influence of bovine serum proteins in experimental dendritic cell-based vaccination protocolsQ73579418
Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cellsQ77924901
Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infectionQ79317485
Close encounters of neutrophils and DCsQ81257740
Microbial antigen triggers rapid mobilization of TNF-alpha to the surface of mouse neutrophils transforming them into inducers of high-level dendritic cell TNF-alpha productionQ81621894
The importance of being a pDC in antiviral immunity: the IFN mission versus Ag presentation?Q81795301
P433issue2
P921main subjectdendritic cellQ506253
tuberculosisQ12204
P304page(s)134-144
P577publication date2006-10-02
P1433published inTuberculosisQ15757844
P1476titleSpecificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model
P478volume87

Reverse relations

cites work (P2860)
Q37371021Antigen-presenting cells transfected with Hsp65 messenger RNA fail to treat experimental tuberculosis.
Q38887861Overview of dendritic cell-based vaccine development for leishmaniasis
Q28473223Protective immunity to Mycobacterium tuberculosis infection by chemokine and cytokine conditioned CFP-10 differentiated dendritic cells
Q37746200Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice.
Q37652470The role of dendritic cells in mycobacterium-induced granulomas
Q50656736Therapeutic protein deimmunization by T-cell epitope removal: antigen-specific immune responses in vitro and in vivo.
Q37754908Tuberculosis vaccines: present and future

Search more.